Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$4.89 - $10.57 $48 - $105
10 Added 0.32%
3,138 $31,000
Q1 2023

May 02, 2023

SELL
$5.62 - $11.51 $10,925 - $22,375
-1,944 Reduced 38.33%
3,128 $18,000
Q4 2022

Feb 02, 2023

BUY
$2.32 - $10.97 $1,791 - $8,468
772 Added 17.95%
5,072 $40,000
Q3 2022

Nov 07, 2022

BUY
$3.09 - $9.21 $13,287 - $39,603
4,300 New
4,300 $15,000

Others Institutions Holding ICVX

About Icosavax, Inc.


  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.